- Imran M, Arshad MS, Butt MS, et al. Mangiferin: a natural miracle bioactive compound against lifestyle related disorders. Lipids Health Dis. 2017;16(1):84.
- Telang M, Dhulap S, Mandhare A, et al. Therapeutic and cosmetic applications of mangiferin: a patent review. Expert Opin Ther Pat. 2013;23(12):1561–1580.
- Bulugonda RK, Gangappa D, Beeda H, et al. Mangiferin from Pueraria tuberosa reduces inflammation via inactivation of NLRP3 inflammasome. Sci Rep. 2017;7:42683.
- Picot MCN, Zengin G, Mollica A, et al. In vitro and in silico studies of mangiferin from aphloia theiformis on key enzymes linked to diabetes type 2 and associated complications. Med Chem. 2017;13(7):633.
- Ehianeta TS, Laval S, Yu B. Bio‐and chemical syntheses of mangiferin and congeners. Biofactors. 2016;42(5):445–458.
- Khurana RK, Kaur R, Lohan S, et al. Mangiferin: a promising anticancer bioactive. Pharm Pat Anal. 2016;5(3):169–181.
- Du S, Liu H, Lei T, et al. Mangiferin: an effective therapeutic agent against several disorders. Mol Med Rep. 2018;18; 1(6):4775–4786..
- Unannounced Inventor, Shi K. New application of isomangiferin. CN104042604; 2014.
- Chae S, Rang A Korea Institute of Oriental Medicine. Composition for preventing, improving or treating skin wrinkle comprising hexane fraction of Anemarrhena asphodeloides extract or isomangiferin isolated from Anemarrhena asphodeloides extract as effective compeonent. KR2018075081; 2016.
- Gao X, Gong Y, Song L; et al. KPC Pharmaceuticals Inc. One kind of mango leaf extract and its application. CN103768112; 2012.
- Yang X, Gao X, Song L; et al. Kunming Pharmaceutical Corp. Application of 3-methoxy-mangiferin after drug for treating depression in stroke. CN103191141; 2012.
- Hua N, Yang Z, Zhao Y, et al. Tonghua Huaxia Pharmaceutical Co. Ltd.; Hua Yu-qiang. Application of neomangiferin in vascular endothelial cell protection. CN107397754; 2017.
- Li X, Shi Z. Shanghai Dia Kate Biomedical Technology Co. Ltd. Application of new mangiferin to prevention and treatment of diabetic nephropathy. CN103356665; 2012.
- Kim YH, Kwon HM. University-Industry Cooperation Group of Kyung Hee University. Composition for suppressing proliferation of adipose stem cells and promoting browning of adipose tissue. KR2017129164; 2015.
- Yu JH, Lee SH. LG Household & Health Care Ltd. C omposition for prevention or treatment of dental disease comprising neomangiferin. KR2017139977; 2016.
- Li X, Liu Y, Song L; et al. Kpc Pharmaceuticals Inc.; Yunnna Mangtai Hypeluricemia Gout Research Centre. The medicament mango and aglycone derivatives in the manufacture of anti-prostate hyperplasia. CN104013611; 2014.
- Suo X. Guangdong Pharmaceutical University. Preparation method of mangiferin aglycon dispersible tablet and application of mangiferin aglycon dispersible tablet. CN105012252; 2014.
- Li X, Liang J. Guangxi University of Chinese medicine. Medicine with blood pressure reducing effect and production method of medicine. CN104873488; 2015.
- Huang Y, Du Z, Li X, et al. Guangxi University of Chinese medicine. Medicine capable of stabilizing vascular plaques CN104188954; 2014.
- Du Z, Huang Y, Li X Guangxi University of Chinese medicine. A pharmaceutical formulation. CN104257650; 2014.
- Li X, Liang J, Zhou J Guangxi University of Chinese medicine. Medicament for reducing blood fat. CN104887660; 2015.
- Li M, Wang B, Pan L, et al. Wuxi Wanquan Pharmaceutical Technology Co. Ltd. Application of compound DZCY06 in preparation of drugs for treating diabetes. CN103816153; 2013.
- Su X, Lei J, Peng B, et al. Northeast Pharmaceutical Group Co. Ltd. Application of berberine and bacillus licheniformis composition in preparation of drug for preventing or treating diseases caused rotavirus infection. CN106420841; 2016.
- Han Q, Lu A, Bian Z, et al. Shanghai University of traditional Chinese medicine;Hong Kong Baptist University. Anti-enterovirus 71 steroidal saponins and their preparation. US20150196612; 2014.
- Du Z, Deng J. Guangxi University of Chinese medicine. Mangiferin-cis-platinum composition and use thereof for treating cancer. CN103110660; 2013.
- Liu Y, Li X, Shang J, et al. KPC Pharmaceuticals Inc.;Yunnna Mangtai Hypeluricemia Gout Research Centre Application of mango aglycone derivative in the manufacture of a medicament prevention of diabetes and its complications. CN104288139; 2014.
- Zhao J, Zhou R. KPC Pharmaceuticals Inc. Compound, preparation method and application thereof, pharmaceutical composition and preparation. CN103755692; 2014.
- Zhao J,Zhou R. KPC Pharmaceuticals Inc. Compound, preparation method and application thereof, pharmaceutical composition and preparation. CN103755693. 2014
- Katti K, Khhobchandani M, Khan A, et al. Univ Missouri. Ayurvedic encapsulated gold nanoparticles, fabrication methods and cancer therapeutic methods. WO2018152002; 2018.
- Li X. Guangxi university of Chinese medicine. Parasite repellent and preparation method thereof. CN104873486; 2015.
- Lin Z, Teng H, Wu W; et al. Changzhou Deze Medical Science Co. Ltd. Mangiferin-6-o-berberine salt and preparation method and use thereof. WO2016110250; 2016.
- Hou S, Wang F, Li Y, et al. Pharmacokinetic study of mangiferin in human plasma after oral administration. Food Chem. 2012;132; 1(1):289–294.
- Gao X, Hu L, Liu E, et al. Tianjin University of traditional Chinese medicine. Mangiferin one kind of composition and its preparation and use. CN103768016; 2014.
- Gao X, Hu L, Wang Y, et al., Univ Tianjin traditional Chinese medicine. Mangiferin preparation and application thereof. CN105796480; 2016.
- Liu X, Sun J, Zhang T; et al. Shenyang Pharmaceutical University. Mangiferin-phosphatide compound and its preparation method and use. CN103961714; 2013.
- Zhang J, Lei T, Zhao H, et al. Univ Chongqing Medical. Oil-in-water nano-emulsion capable of obviously improving bioavailability of insoluble medicament and preparation method for oil-in-water nano-emulsion. CN106038488; 2016.
- Zhang J, Chen J, Jiang X, et al. Univ Chongqing Medical. Water-in-oil type nano-emulsion capable of obviously improving bioavailability of poorly water-soluble drugs and preparation method of water-in-oil type nano-emulsion. CN105997875; 2016.
- Katti K, Cutler C, Khoobchandani M.Univ Missouri. Mangiferin encapsulated gold nanoparticles, fabrication methods and cancer therapeutic methods. WO2018067570; 2017.
- Deng J, Huang J, Li X, et al. Univ Guangxi traditional Chinese medical. Multi-element mangiferin solid dispersion as well as preparation method and application thereof. CN104473875; 2014.
- Barzilay A, Rozner D, Barzilay A; Vital Beverages Global Inc. Compositions and methods for selective gi tract delivery. US2017290768; 2015.
- Barr WH, Gerk PM, Ritter JK, et al. Univ Virginia commonwealth; Gerk P M; Barr W H; et al. Selective metabolic approach to increasing oral bioavailability of phenylephrine and other phenolic bioactivities. US20140221426; 2012.
- Bai Y, Dong S. Third Military Medical University of Chinese PLA. Application of mangiferin in preparing drug for promoting bone defect repair. CN107496413; 2017.
- Particle Analytical. Kingdom of Denmark. [ Cited 2019 Feb 3]. Available from http://particle.dk/what-is-a-polymorph/
- Lu Y, Du G, Zhou Q, et al. Chinese Acad Medical Sci.Mangiferin crystal form-V matter as well as preparation method, composition and use thereof. CN108239079; 2016.
- U Y, Du G, Zhou Q; et al. Chinese Acad Medical Sci. Mangiferin crystal form-VI matter as well as preparation method, composition and use thereof. CN108239080; 2016.
- Bhagwat M, Kaushik G, Shivpuje V. Second medical use patenting: a review of practices across different jurisdictions. J Intellect Prop Rights. 2016;21:260–264.
- Sonderhoff & Einsel News Update: China IP Newsletter (May 2018). [ Cited 2019 Feb 12].
- Khare P, Shanker K. Mangiferin: a review of sources and interventions for biological activities. Biofactors. 2016;42; 10(5):504–514.
- Ma H, Chen H, Sun L, et al. Improving permeability and oral absorption of mangiferin by phospholipid complexation. Fitoterapia. 2014;93; 31:54–61.
- Tian X, Gao Y, Xu Z, et al. Pharmacokinetics of mangiferin and its metabolite—norathyriol, Part 1: systemic evaluation of hepatic first‐pass effect in vitro and in vivo. Biofactors. 2016;42; 10(5):533–544.
- de Souza JR, Feitosa JP, Ricardo NM, et al. Spray-drying encapsulation of mangiferin using natural polymers. Food Hydrocoll. 2013;33; 1(1):10–18.
- Xiao W, Hou J, Ma J, et al. Mangiferin loaded magnetic PCEC microspheres: preparation, characterization and antitumor activity studies in vitro. Arch Pharm Res. 2014;30:1–7.
- Wang X, Gu Y, Ren T, et al. Increased absorption of mangiferin in the gastrointestinal tract and its mechanism of action by absorption enhancers in rats. Drug Dev Ind Pharm. 2013;39; 1(9):1408–1413.
- Khurana RK, Bansal AK, Beg S, et al. Enhancing biopharmaceutical attributes of phospholipid complex-loaded nanostructured lipidic carriers of mangiferin: systematic development, characterization and evaluation. Int J Pharm. 2017;518; 25(1–2):289–306.
- Pu J, Yang Z, Zhou R. Kunming pharmaceutical corp. Mangiferin aglycone crystal forms, and composition, preparation method and application thereof. CN102351835; 2011.
- Huang Y, Li X, Zhou J. Guangxi University of Chinese Medicine. Medicine with anti-hepatic fibrosis effect. CN104873487; 2015.
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research